Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Rx Import Plan Has Administration Support - If Funding Is Sufficient

Executive Summary

FDA estimates that it will need $23 mil. in new appropriations to set up a system to oversee pharmaceutical importation under the approach included in the Senate version of the agriculture appropriations bill.

You may also be interested in...



Federal Policymakers In Brief

New Obama budget chief: President Barack Obama announced his nomination of Jacob (Jack) Lew to head the White House Office of Management and Budget on July 13. Currently the deputy secretary of state for management and resources, Lew has held a variety of federal posts, including heading OMB from 1998 to 2001 during the Clinton administration. During that earlier tenure, Lew issued policy statements on issues including the need to provide adequate safety oversight funding as part of any drug importation legislation (1"The Pink Sheet," Sept. 25, 2000) and urging a federal, rather than state block grant, approach to providing Medicare drug coverage (2"The Pink Sheet," Sept. 18, 2000). He also had been chief domestic policy advisor for several years for House Speaker Tip O'Neill, D-Mass. Current OMB Director Peter Orszag is expected to depart at the end of July

Federal Policymakers In Brief

New Obama budget chief: President Barack Obama announced his nomination of Jacob (Jack) Lew to head the White House Office of Management and Budget on July 13. Currently the deputy secretary of state for management and resources, Lew has held a variety of federal posts, including heading OMB from 1998 to 2001 during the Clinton administration. During that earlier tenure, Lew issued policy statements on issues including the need to provide adequate safety oversight funding as part of any drug importation legislation (1"The Pink Sheet," Sept. 25, 2000) and urging a federal, rather than state block grant, approach to providing Medicare drug coverage (2"The Pink Sheet," Sept. 18, 2000). He also had been chief domestic policy advisor for several years for House Speaker Tip O'Neill, D-Mass. Current OMB Director Peter Orszag is expected to depart at the end of July

Rx Drug Import Language By GOP Leaders Has Three-Year Sunset Provision

Prescription drug importation language proposed by the House and Senate Republican leadership includes a three-year sunset provision.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036669

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel